clotrimazole has been researched along with Benign Neoplasms, Brain in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cultured C6 and 9L glioma cells were exposed to clotrimazole, and cell growth was assessed using the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide colorimetric assay." | 7.73 | Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole. ( Caputy, AJ; Khalid, MH; Tokunaga, Y; Walters, E, 2005) |
| "Plerixafor (AMD3100) is a new small molecular weight inhibitor of CXCR4, FDA approved to aid in stem cell mobilization." | 5.36 | Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. ( Kast, RE, 2010) |
| "Cultured C6 and 9L glioma cells were exposed to clotrimazole, and cell growth was assessed using the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide colorimetric assay." | 3.73 | Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole. ( Caputy, AJ; Khalid, MH; Tokunaga, Y; Walters, E, 2005) |
| "Whipple disease is a rare infection caused by the bacterium Tropheryma whippelii." | 2.42 | Whipple disease confined to the central nervous system presenting as a solitary frontal tumor. Case report. ( Deckert, M; Gross, WP; Klug, N; Löhr, M; Plum, G; Stenzel, W, 2004) |
| "Plerixafor (AMD3100) is a new small molecular weight inhibitor of CXCR4, FDA approved to aid in stem cell mobilization." | 1.36 | Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. ( Kast, RE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, K | 1 |
| Yao, YL | 1 |
| He, ZC | 1 |
| Chen, C | 1 |
| Zhang, XN | 1 |
| Yang, KD | 1 |
| Liu, YQ | 1 |
| Liu, Q | 1 |
| Fu, WJ | 1 |
| Chen, YP | 1 |
| Niu, Q | 1 |
| Ma, QH | 1 |
| Zhou, R | 1 |
| Yao, XH | 1 |
| Zhang, X | 1 |
| Cui, YH | 1 |
| Bian, XW | 1 |
| Shi, Y | 1 |
| Ping, YF | 1 |
| Kast, RE | 1 |
| Löhr, M | 1 |
| Stenzel, W | 1 |
| Plum, G | 1 |
| Gross, WP | 1 |
| Deckert, M | 1 |
| Klug, N | 1 |
| Khalid, MH | 1 |
| Tokunaga, Y | 1 |
| Caputy, AJ | 1 |
| Walters, E | 1 |
1 review available for clotrimazole and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Whipple disease confined to the central nervous system presenting as a solitary frontal tumor. Case report.
Topics: Adult; Antifungal Agents; Brain Neoplasms; Central Nervous System Bacterial Infections; Clotrimazole | 2004 |
3 other studies available for clotrimazole and Benign Neoplasms, Brain
| Article | Year |
|---|---|
VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Plasticity; Clotrimazole; Gene Knockdown Techniques | 2018 |
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct.
Topics: Antifungal Agents; Benzylamines; Brain Neoplasms; Clotrimazole; Cyclams; Drug Synergism; Glioblastom | 2010 |
Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Pro | 2005 |